| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insight Molecular Diagnostics Inc. (IMDX) has 7 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. IMDX is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 12.68M | $69.01M | - | |
| CEO | 400.0K | $2.18M | - | |
| CFO | 201.2K | $1.09M | - | |
| Dir | 136.6K | $742.9K | - | |
| Dir | 39.5K | $214.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | James Andrea S.68 | Chief Financial Officer | Buy | 20,000 | $2.29 | $45,800.00 | +59.4% | +57.4% | +127.8% | |
| Oct 2, 2024 | James Andrea S.68 | Chief Financial Officer | Buy | 33,670 | $2.97 | $99,999.90 | New | -22.0% | +9.5% | |
| Oct 2, 2024 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 1,315,339 | $2.95 | $3,877,619.37 | +11.8% | -22.0% | +9.5% | |
| Apr 11, 2024 | Riggs Josh | CEO And President | Buy | 3,390 | $2.95 | $10,000.50 | +2,948% | +1.9% | -6.2% | |
| Apr 11, 2024 | Arno Andrew | Director | Buy | 33,898 | $2.95 | $99,999.10 | +96.4% | +1.9% | -6.2% | |
| Apr 11, 2024 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 2,420,000 | $2.92 | $7,057,688.00 | +32.5% | +1.9% | -6.2% | |
| Jun 14, 2023 | Kingsley Alfred D | Director | Buy | 30,000 | $0.21 | $6,447.00 | +6.8% | -23.9% | -38.0% | |
| Apr 5, 2023 | Pura Vida Investments, LLC | 10% Owner | Buy | 663,000 | $0.30 | $200,027.10 | +8.9% | -17.7% | -45.6% | |
| Apr 3, 2023 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 26,827,638 | $0.30 | $8,093,898.38 | +36.5% | -27.7% | -53.9% | |
| Dec 23, 2022 | Gutfreund John Peter | Director | Buy | 75,000 | $0.33 | $24,727.50 | New | -39.0% | -65.9% |